Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter? - Wikidata - awgldk - TriplyDB

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

http://www.wikidata.org/entity/Q48362853

about

Reply to Chang et al., "Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?"

P2860

Q54296806-8DC9D76B-56F4-4F27-984F-1F87D10BE32C

P2860

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

http://www.wikidata.org/entity/Q48362853

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@en

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@nl

type

label

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@en

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@nl

prefLabel

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@en

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@nl

P1433

Q48362853-9496A9EA-9151-4C61-A268-3FDF7B67646E

P1476

Q48362853-6CFC1862-5FCB-4D6E-97C5-28155C38820A

P2093

Q48362853-8DE748AD-8B58-4EAC-9F41-732ABB8536F7

Q48362853-A312C4B6-E591-45EA-8AD4-3CB006094B71

P2860

Q48362853-0541F41F-693D-455C-B1FA-DA64487D6D75

Q48362853-06A88600-AB8F-45CB-8B76-92F14AF884DE

Q48362853-075955DF-5FB5-4C1A-A2EB-C4F54630DEF4

Q48362853-0A5397A4-F99D-4DB3-8F53-410ED9659E29

Q48362853-113FCF8D-A936-40E2-AC26-D002BD536E90

Q48362853-12F75163-172E-4C8B-82E9-736115FDAD79

Q48362853-1E93DC71-9DA4-4070-8588-88527090CEFE

Q48362853-234C55D7-35D0-46E4-AF24-CD78CB305DE3

Q48362853-2C204C7A-4738-4489-8A0E-B5C10FE1D5E0

Q48362853-49584B57-928A-4DD2-8B3A-0F444E605D40

P31

Q48362853-1C3D6293-6D06-4DEC-80E4-30D72E8DDC99

P356

Q48362853-469CB149-3C34-4304-BF43-65B94B1859CD

P407

Q48362853-F04AA722-83B7-4173-A5B1-EDC09D413484

P433

Q48362853-4133608B-BCA7-4351-A6C7-7E17395690C1

P478

Q48362853-740F7333-838E-471E-BAD6-59ED56632F55

P50

Q48362853-887B40A8-62E1-46A7-AF13-2131B9400B07

P577

Q48362853-C9A4069C-EFE2-4406-8DE4-EBB954C9F45E

P698

Q48362853-A78BB33E-62FF-414E-BA5F-EBC594AEED5E

P932

Q48362853-EC44D17D-7A3E-4D32-9167-EDA97D79A672

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?

@en

P2093

Wing-Wai Yew

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

The curious characteristics of pyrazinamide: a review

pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada

Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase

Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform

A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis

P31

scholarly article

P356

10.1128/AAC.01907-17

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Kwok Chiu Chang

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29269428

http://www.w3.org/2001/XMLSchema#string

P932

5740308

http://www.w3.org/2001/XMLSchema#string